It's a follow up study from Project Teal 3, which assessed self-sampling for primary cervical cancer screening in under-screened women in the HK female population.

Teal 3.1 commenced on Q4 of 2022 and the Foundation, together with its project partners will assess if self-collection of vaginal samples, urine or menstrual blood for screening of cervical cancer can replace clinician collected samples.

The study will cover 200 women who have been diagnosed with high-risk HPV and assess how the knowledge of additional bio markers collected via self-sampling, may positively contribute to the future disease screening.